Enanton Market

Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.

Enanton Market contains market size and forecasts of Enanton (Leucorin Acetate) in global, including the following market information:

Global Enanton (Leucorin Acetate) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Enanton (Leucorin Acetate) Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Enanton (Leucorin Acetate) companies in 2021 (%)

The global Enanton (Leucorin Acetate) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Leucorin Acetate For Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Enanton (Leucorin Acetate) include Sanofi, TOLMAR, Teva, Sandoz (Novartis), SciAnda Pharma, Daewoong, Nanox, GP Pharm and Enteris BioPharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Enanton (Leucorin Acetate) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Enanton (Leucorin Acetate) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Enanton (Leucorin Acetate) Market Segment Percentages, by Type, 2021 (%)

Leucorin Acetate For Injection

Liulinruilin Acetate Injection

Global Enanton (Leucorin Acetate) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Enanton (Leucorin Acetate) Market Segment Percentages, by Application, 2021 (%)

Breast Cancer

Endometriosis

Uterine Fibrosis

Prostate Cancer

Infertility

Precocious Puberty

Other

Global Enanton (Leucorin Acetate) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Enanton (Leucorin Acetate) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Enanton (Leucorin Acetate) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Enanton (Leucorin Acetate) revenues share in global market, 2021 (%)

Key companies Enanton (Leucorin Acetate) sales in global market, 2017-2022 (Estimated), (KG)

Key companies Enanton (Leucorin Acetate) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sanofi

TOLMAR

Teva

Sandoz (Novartis)

SciAnda Pharma

Daewoong

Nanox

GP Pharm

Enteris BioPharma

Xbrane Biopharma

Camurus

Chong Kun Dang

Takeda